ACADIA Pharmaceuticals(ACAD) - 2024 Q2 - Earnings Call Presentation

○ ACADIA Second Quarter 2024 Earnings Call August 6, 2024 Call Agenda Welcome Al Kildani | Senior Vice President, Investor Relations and Corporate Communications CEO Opening Remarks Steve Davis | President and Chief Executive Officer Commercial Update Brendan Teehan | Chief Operating Officer, Head of Commercial R&D Update Elizabeth Thompson | Executive Vice President, Head of Research and Development Financial Update Mark Schneyer | Chief Financial Officer Closing Remarks Steve Davis | President and Chief E ...